Increasing Use of Stem Cell Therapy is Paving New Growth Avenues for Players in the Nerve Repair Market

Nerve repair and regeneration products are used by medical professionals to restore normal function to damaged nerves. Nerve injuries are common in the upper (hand and arm) and lower (leg) extremities. Nerve damage can be caused either due to blunt trauma (such as an impact from a fall or from traction injuries from motor vehicle accidents) or sharp trauma (such as from a direct cut from a knife). Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings.

The Nerve Repair and Regeneration Market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Major Market Developments:-

• In June 2015, Boston Scientific launched precision novi spinal cord stimulator system in Europe and received CE Mark approval for it
• In January 2016, Polyganics (the Netherlands) signed an agreement with MicroAire Surgical Instruments (US) to distribute its peripheral nerve repair products in the US and Canada
• In January 2017, Abbott Laboratories acquired St. Jude Medical to strengthen its position in the neuromodulation market
•  In September 2017, Medtronic (Ireland) received FDA approval Intellis platform spinal cord stimulator (SCS)
• In May 2015, Axogen (US) received FDA approval for Avance nerve graft

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883  

Market Drivers:-

• High incidence of nerve injuries and growing prevalence of neurological disorder
• Increase in geriatric population and subsequent growth in the prevalence of neurological disorder
• Technological advancement

Regional Analysis:-

By region, the nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe; however, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; large population; growth in the number of hospitals, and increasing neurological disorders in the region are some of the key factors driving the high growth of this regional segment.

Read more: - https://www.marketsandmarkets.com/PressReleases/nerve-repair-regeneration.asp

Top key Players:-
Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

Leading Players in the Nerve Repair and Regeneration Market

The research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022", The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

By neurostimulation and neuromodulation device product, the internal neurostimulation device segment is expected to dominate the market in 2017

On the basis of neurostimulation and neuromodulation device product is subsegmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883

By end user, the hospitals and clinics segment is expected to dominate the market in 2017
In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

Browse and in-depth TOC on “Nerve Repair and Regeneration Market”

83 - Tables

31 - Figures

122 - Pages

Asia offers lucrative growth opportunities By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.

Know more: - https://www.marketsandmarkets.com/PressReleases/nerve-repair-regeneration.asp

Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

Nerve Repair and Regeneration Market | Increasing Incidences of Peripheral Nerve Injuries & Neurological Disorders

The  research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022", The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Further more information in details about Nerve Repair and Regeneration Market Best Chance to increase growth in revenue of your company. 



The nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.
 

Nerve Repair and Regeneration Market: Technological Advancements in Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps & Neurostimulation Devices | Trends 2018

According to the new market research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022".

On the basis of neurostimulation and neuromodulation device product is subsegmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

Browse and in-depth TOC on “Nerve Repair and Regeneration Market”.

http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html

In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=883

By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, 

Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).